已收录 268921 条政策
 政策提纲
  • 暂无提纲
The tyrosine kinase inhibitor GNF‐2 suppresses osteoclast formation and activity
[摘要] GNF‐2,atyrosinekinaseinhibitor,wasdevelopedtoovercomeimatinib‐resistantmutationsfoundinCMLpatients.Osteoclastsaretheprincipalbone‐resorbingcellsthatareresponsibleforbonediseases,suchasosteoporosis,tumor‐inducedosteolysis,andmetastaticcancers.Inthisstudy,weinvestigatedtheeffectofGNF‐2onosteoclastdevelopmentinducedbyRANKLandM‐CSF.WefoundthatGNF‐2inhibitedosteoclastdifferentiationfromBMMs.GNF‐2suppressedRANKL‐inducedNF‐κBtranscriptionalactivityandtheinductionofc‐FosandNFATc1,whicharetwokeytranscriptionfactorsinosteoclastogenesis.WealsoobservedthatGNF‐2dose‐dependentlyinhibitedtheproliferationofosteoclastprecursorsthroughthesuppressionoftheM‐CSFRc‐Fms.Inaddition,GNF‐2acceleratedosteoclastapoptosisbyinducingcaspase‐3andBimexpression.Furthermore,GNF‐2interferedwithactincytoskeletalorganizationandsubsequentlyblockedthebone‐resorbingactivityofmatureosteoclasts.Inagreementwithitsinvitroeffects,GNF‐2reducedosteoclastnumberandbonelossinamousemodelofLPS‐inducedbonedestruction.Takentogether,ourdatarevealthatGNF‐2possessesanti‐bone‐resorptiveproperties,suggestingthatGNF‐2mayhavetherapeuticvalueforthetreatmentofbone‐destructivedisordersthatcanoccurasaresultofexcessiveosteoclasticboneresorption...
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 生理学
[关键词] osteoporosis;NF‐κB;c‐Fos;c‐Fms;LPS [时效性] 
   浏览次数:24      统一登录查看全文      激活码登录查看全文